Skip to main content

Cancer News - Studies/Clinical Trials/Research

News related to clinical trials of cancer drugs and treatments.

Researchers examine mechanisms that help cancer cells proliferate

Researchers examine mechanisms that help cancer cells proliferate

DALLAS — Sept. 1, 2009 — A process that limits the number of times a cell divides works much differently than had been thought, opening the door to potential new anticancer therapies, researchers at UT Southwestern Medical Center report in the Aug. 7 issue of the journal Cell.

http://www.utsouthwestern.edu/utsw/cda/dept353744/files/546195.html

ShareThis

PET/CT Scans May Help Detect Recurring Prostate Cancer Earlier

PET/CT Scans May Help Detect Recurring Prostate Cancer Earlier

ScienceDaily (Sep. 1, 2009) — A new study published in the September issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET)/computer tomography (CT) scans with the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some patients who have had their prostates surgically removed.

http://www.sciencedaily.com/releases/2009/09/090901150955.htm

ShareThis

Antioxidants Not Associated With Increased Melanoma Risk

Antioxidants Not Associated With Increased Melanoma Risk

ScienceDaily (Sep. 1, 2009) — Antioxidant supplements do not appear to be associated with an increased risk of melanoma, according to a new report.

http://www.sciencedaily.com/releases/2009/08/090817184543.htm

ShareThis

New hope for deadly childhood bone cancer

New hope for deadly childhood bone cancer

SALT LAKE CITY, Aug. 31, 2009 -- Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have shed new light on Ewing's sarcoma, an often deadly bone cancer that typically afflicts children and young adults.

http://www.scienceblog.com/cms/new-hope-deadly-childhood-bone-cancer-245...

ShareThis

Markers Can Predict More Aggressive Pancreatic Tumors

Markers Can Predict More Aggressive Pancreatic Tumors
Study finds impaired blood flow and high metabolism predict poor survival

MONDAY, Aug. 31 (HealthDay News) -- Blood flow is impaired and metabolism is enhanced in pancreatic tumors, and a high ratio of metabolism to blood flow predicts poor survival, according to a study published online Aug. 25 in Clinical Cancer Research.

http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Markers...

ShareThis

Tumors Feel The Deadly Sting Of Nanobees

Tumors Feel The Deadly Sting Of Nanobees

ScienceDaily (Aug. 31, 2009) — When bees sting, they pump poison into their victims. Now the toxin in bee venom has been harnessed to kill tumor cells by researchers at Washington University School of Medicine in St. Louis. The researchers attached the major component of bee venom to nano-sized spheres that they call nanobees.

http://www.sciencedaily.com/releases/2009/08/090810174226.htm

ShareThis

Molecular testing: Multimarker assay demonstrates high accuracy in melanoma diagnosis

Molecular testing: Multimarker assay demonstrates high accuracy in melanoma diagnosis

San Francisco — A molecular test analyzing the intensity and distribution of expression of a handful of proteins in melanocytic lesions appears to provide a highly accurate method for discriminating between benign nevi and malignant melanoma.

http://www.modernmedicine.com/modernmedicine/Oncology+Cover/Molecular-te...

ShareThis

Research Points To New Target For Stopping Colon Cancer

Research Points To New Target For Stopping Colon Cancer

ScienceDaily (Aug. 31, 2009) — Drugs that target the epidermal growth factor receptor, or EGFR, have been used for a number of cancers. But these drugs called EGFR inhibitors, such as cetuximab, have not been very effective against colon cancer.

http://www.sciencedaily.com/releases/2009/08/090817184537.htm

ShareThis

Delivery Of Cancer-fighting Molecules Improved

Delivery Of Cancer-fighting Molecules Improved

ScienceDaily (Aug. 27, 2009) — Small interfering RNA (siRNA), a type of genetic material, can block potentially harmful activity in cells, such as tumor cell growth. But delivering siRNA successfully to specific cells without adversely affecting other cells has been challenging.

http://www.sciencedaily.com/releases/2009/08/090827123212.htm

ShareThis

New Target For Treating Breast Cancer Metastasis

New Target For Treating Breast Cancer Metastasis

ScienceDaily (Aug. 26, 2009) — Dr. Amanda Harvey and colleagues at Brunel University have demonstrated that the protein Brk plays a role in breast cancer progression and dissemination. Their report can be found in the September 2009 issue of the American Journal of Pathology.

http://www.sciencedaily.com/releases/2009/08/090826110116.htm

ShareThis
Syndicate content